LA Times owner offers $210million to create new Covid vaccines in South Africa
3 years, 7 months ago

LA Times owner offers $210million to create new Covid vaccines in South Africa

The Independent  

The latest headlines from our reporters across the US sent straight to your inbox each weekday Your briefing on the latest headlines from across the US Your briefing on the latest headlines from across the US SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy A US billionaire has announced he will offer 3bn South African rand to South Africa, where he was born, to help create coronavirus vaccines. “Our goal and our commitment is to come back to South Africa and transfer this kind of technology,” Dr Soon-Shiong reportedly said at an international meeting on the equitable distribution of coronavirus vaccines. Referring to South Africa, he said, “Not only do we have the science, we have the human capital and the capacity and the desire.” During the meeting, which was co-chaired by the director-general of the World Health Organisation, the biotech billionaire said that the transfer of technology was as important as waiving intellectual property rights to shots. Biovac, one of the two manufacturers producing vaccines in South Africa, said it would partner with Dr Soon-Shiong’s company ImmunityBio to help produce experimental coronavirus vaccines, which are currently undergoing clinical trials, The Times reported.

History of this topic

Macron and African leaders push for vaccines for Africa after COVID-19 exposed inequalities
6 months, 2 weeks ago
African and European leaders push for vaccines for Africa after COVID-19 exposed inequalities
6 months, 2 weeks ago
Gates Foundation funding $40 million effort to help develop mRNA vaccines in Africa in coming years
1 year, 3 months ago
Gates Foundation funding $40 million effort to help develop mRNA vaccines in Africa in coming years
1 year, 3 months ago
Scientists whose work on mRNA paved the way for first COVID-19 vaccines win Nobel Prize
1 year, 3 months ago
Time of Pandemics
2 years, 9 months ago
WHO chief praises South Africa’s work to make COVID vaccines
2 years, 10 months ago
Omicron: Vaccine nationalism will only perpetuate the pandemic
3 years, 1 month ago
African Union to buy up to 110 million Moderna COVID vaccines
3 years, 2 months ago
Africa tries to end vaccine inequity by replicating its own
3 years, 2 months ago
WHO aims for 30 percent of needed Africa COVID jabs by February
3 years, 3 months ago
Vaccine inequalty: African countries to receive six million Johnson and Johnson vaccines
3 years, 5 months ago
South African firm to make Pfizer vaccine, first in Africa
3 years, 5 months ago
South African firm to make Pfizer vaccine, first in Africa
3 years, 5 months ago
South Africa's new coronavirus cases surge to record levels
3 years, 6 months ago
Vaccine technology transfer center to open in South Africa
3 years, 6 months ago
L.A. Times owner pledges $213 million for COVID-19 vaccine work in South Africa
3 years, 7 months ago
March 31, 2021 coronavirus news
3 years, 9 months ago
Here’s what Covid vaccines are worth to Big Pharma
3 years, 9 months ago
Johnson & Johnson: The race to manufacture Covid-19 vaccines at record speed
3 years, 10 months ago
Ghana receives first COVID vaccine through UN-backed COVAX scheme
3 years, 10 months ago
World is on course for a coronavirus vaccine ‘apartheid’, experts warn
3 years, 10 months ago
Global health officials back AstraZeneca vaccine after South Africa study rings alarm
3 years, 11 months ago
South Africa to halt rollout of AstraZeneca coronavirus vaccine, but experts say it's 'too early' to evaluate impact on Australia
3 years, 11 months ago
South Africa’s coronavirus strain upends country’s vaccination plans
3 years, 11 months ago
Rich countries hoarding COVID-19 vaccines, says South African President Ramaphosa
3 years, 11 months ago
Colombia says it's ready to distribute coronavirus vaccines
3 years, 11 months ago
COVID vaccines in Africa to be allocated by population
3 years, 11 months ago
270 million extra Covid vaccine doses secured for Africa
3 years, 11 months ago
South Africa to receive first COVID vaccines in January
4 years ago
China's Sinovac Aims for 600 Million Dose Capacity for Covid-19 Vaccine
4 years, 1 month ago
Coronavirus cases in Indonesia surpass half million as China vaccine trial continues
4 years, 1 month ago
Coronavirus vaccine update: Setback for Sputnik V in India, report says AstraZeneca could see profits in July
4 years, 3 months ago
Rich Nations Have Cornered More Than Half of Future Covid-19 Vaccine Supply, Oxfam Says
4 years, 3 months ago
Coronavirus Vaccine Won’t Be Available to Everyone Before End of 2024, Says Serum Institute Chief
4 years, 3 months ago
90% Of China's Sinovac Employees, Families Took Coronavirus Vaccine: CEO
4 years, 4 months ago
90% of China's Sinovac employees, families took Covid-19 vaccine, says CEO
4 years, 4 months ago
The Vaccine Race Has Become A High-Stakes Geopolitical Gamble
4 years, 4 months ago
Trump announces sixth vaccine contract for US, for 100 mn doses of Moderna's COVID-19 vaccine
4 years, 4 months ago
Coronavirus: SII partners with vaccine developers for 100mn doses
4 years, 5 months ago
Won’t profit from COVID-19 vaccine in pandemic, says AstraZeneca
4 years, 5 months ago
US doubles spending on potential coronavirus vaccine to nearly $1 billion
4 years, 5 months ago
Coronavirus vaccine access could come back to old alliances as world powers ramp up search for COVID-19 cure
4 years, 5 months ago
Brazil close to coronavirus vaccine deal, says pharma firm AstraZeneca
4 years, 6 months ago
Africa urges no ‘obstacles’ to a COVID-19 vaccine for all
4 years, 6 months ago
China aims to ‘lead the world’ by winning the coronavirus vaccine race
4 years, 6 months ago
Merck joins race for COVID-19 shots and drugs months after competitors
4 years, 7 months ago
Coronavirus | 80% success chance for Oxford vaccine trials, says Serum Institute chief
4 years, 7 months ago
Highly-anticipated coronavirus vaccine will be produced at large scale, won’t be expensive, says Oxford University professor
4 years, 7 months ago

Discover Related